1. Home
  2. Tyrosine hydroxylase
  Subject:

Tyrosine hydroxylase   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
RELATED SUBJECTS:
The publications listed also have these subjects
Dopamine  19 times
Protein  12 times
Substantia nigra  11 times
Striatum  10 times
Oxidopamine  8 times
MPTP  6 times
Phosphorylation  5 times
Pars compacta  5 times
Oxidative stress  5 times
Western blot  4 times
Synuclein  4 times
Parkinson's disease  4 times
Mouse  4 times
MAPK3  4 times
Immunohistochemistry  4 times
Bcl-2-associated X protein  4 times
Protein kinase B  3 times
Norepinephrine  3 times
Nitric oxide synthase  3 times
Neurodegeneration  3 times
Motor cortex  3 times
Mitogen-activated protein kinase  3 times
Midbrain  3 times
Kinase  3 times
Gene  3 times
Extracellular signal–regulated kinases  3 times
Enzyme inhibitor  3 times
Caspase  3 times
CREB  3 times
Bcl-2  3 times
Tyrosine  2 times
Superoxide dismutase  2 times
Serotonin  2 times
Primate  2 times
Phenotype  2 times
Neurotoxin  2 times
Neuropathology  2 times
Neuron  2 times
NMDA receptor  2 times
Memory  2 times
Lipid peroxidation  2 times
Immunofluorescence  2 times
Hypothalamus  2 times
Hippocampus  2 times
HMOX1  2 times
Growth factor  2 times
Glutamic acid  2 times
Ganglion  2 times
Dopamine transporter  2 times
Cofactor (biochemistry)  2 times
Caspase 3  2 times
Ataxia  2 times
Astrocyte  2 times
Apoptosis  2 times
Antioxidant  2 times
Acid  2 times
Zinc sulfate  1 time
Zinc  1 time
Zebrafish  1 time
Xenopus  1 time
Visual cortex  1 time
Ventricle (heart)  1 time
Vasopressin  1 time
Urea  1 time
Tubulin  1 time
Tryptophan  1 time
Transient receptor potential channel  1 time
Transfection  1 time
Thalamus  1 time
Teleost  1 time
Tegmentum  1 time
Syndrome  1 time
Synaptic plasticity  1 time
Sympathetic nervous system  1 time
Spinal cord  1 time
Spa town  1 time
Small interfering RNA  1 time
Sitagliptin  1 time
Sirtuin 1  1 time
Schizophrenia  1 time
S100 protein  1 time
Rotenone  1 time
Rodent  1 time
Reuptake inhibitor  1 time
Renin–angiotensin system  1 time
Quercetin  1 time
Putamen  1 time
Psychosis  1 time
Pseudorabies  1 time
Protein kinase A  1 time
Prostaglandin-endoperoxide synthase 2  1 time
Prenatal development  1 time
Prefrontal cortex  1 time
Piperidine  1 time
Phosphoinositide 3-kinase  1 time
Pheochromocytoma  1 time
Phenylalanine  1 time
Peristalsis  1 time
Peripheral neuropathy  1 time
Peptide  1 time
Parasympathetic nervous system  1 time
P38 mitogen-activated protein kinases  1 time
Oxytocin  1 time
Olfactory bulb  1 time
Nucleus accumbens  1 time
Nicotine  1 time
Neurofilament  1 time
Naringenin  1 time
NFE2L2  1 time
Mutation  1 time
Multiple system atrophy  1 time
Monoamine oxidase  1 time
Monkey  1 time
Mitochondrion  1 time
Microglia  1 time
Metabolite  1 time
Metabolism  1 time
Messenger RNA  1 time
Mediastinum  1 time
Manganese  1 time
Malondialdehyde  1 time
Liraglutide  1 time
Leucine-rich repeat  1 time
Large intestine  1 time
L-DOPA  1 time
Intravenous therapy  1 time
Intraperitoneal injection  1 time
Infarction  1 time
Immunoassay  1 time
Hydrolase  1 time
Homeostasis  1 time
Global Positioning System  1 time
Glial fibrillary acidic protein  1 time
Genetically modified mouse  1 time
Gastrointestinal tract  1 time
Gamma-Aminobutyric acid  1 time
Free-radical halogenation  1 time
Fatty acid  1 time
Exocytosis  1 time
Esophagus  1 time
Epinephrine  1 time
Enzyme  1 time
Endoplasmic reticulum  1 time
Ejection fraction  1 time
Dopamine receptor  1 time
Dementia  1 time
Danio  1 time
Cytosol  1 time
Cyclooxygenase  1 time
Creatinine  1 time
Cingulate cortex  1 time
Cholinesterase  1 time
Cerebrum  1 time
Cerebrospinal fluid  1 time
Cell surface receptor  1 time
Caudate nucleus  1 time
Catenin  1 time
Catalase  1 time
Carboxylic acid  1 time
Carbonylation  1 time
Capsaicin  1 time
Cannabinoid receptor  1 time
C-jun  1 time
Biomarker  1 time
Benzene  1 time
Before Present  1 time
B-cell lymphoma  1 time
Attention deficit hyperactivity disorder  1 time
Atomoxetine  1 time
Arginine  1 time
Antibody  1 time
Angiotensin  1 time
Amyloid  1 time
Amygdala  1 time
Amide  1 time
Albinism  1 time
Adjuvant therapy  1 time
21 Days  1 time

Publications tagged with this subject: 32

Note: Top 50 publications shown only. Open an item panel to view more info


1. Nanodelivery of Cerebrolysin and Rearing in Enriched Environment Induce Neuroprotective Effects in a Preclinical Rat Model of Parkinson’s Disease

2. Propagation of pathological α-synuclein in marmoset brain

3. Capsaicin Protects Against Oxidative Insults and Alleviates Behavioral Deficits in Rats with 6-OHDA-Induced Parkinson’s Disease via Activation of TRPV1

4. Timed Release of Cerebrolysin Using Drug-Loaded Titanate Nanospheres Reduces Brain Pathology and Improves Behavioral Functions in Parkinson’s Disease

5. The Impact of Short and Long-Term Exercise on the Expression of Arc and AMPARs During Evolution of the 6-Hydroxy-Dopamine Animal Model of Parkinson’s Disease

6. 6-OHDA-Lesioned Adult Zebrafish as a Useful Parkinson’s Disease Model for Dopaminergic Neuroregeneration

7. Effect of Intrastriatal 6-OHDA Lesions on Extrastriatal Brain Structures in the Mouse

8. Regenerative medicine for Parkinson’s disease using differentiated nerve cells derived from human buccal fat pad stem cells

9. Psychosis in Spinocerebellar Ataxias: a Case Series and Study of Tyrosine Hydroxylase in Substantia Nigra

10. Three Types of A11 Neurons Project to the Rat Spinal Cord

11. Alterations in the reduced pteridine contents in the cerebrospinal fluids of LRRK2 mutation carriers and patients with Parkinson’s disease

12. Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice

13. Effects of renal denervation on cardiac oxidative stress and local activity of the sympathetic nervous system and renin-angiotensin system in acute myocardial infracted dogs

14. Enteric neurons of the esophagus: an immunohistochemical study using donated elderly cadavers

15. Molecular mechanisms of synthesis of noradrenaline as an inducer of development in the adrenal glands of rats in ontogenesis

16. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress

17. URB597 and the Cannabinoid WIN55,212-2 Reduce Behavioral and Neurochemical Deficits Induced by MPTP in Mice: Possible Role of Redox Modulation and NMDA Receptors

18. On the Role of DT-Diaphorase Inhibition in Aminochrome-Induced Neurotoxicity In Vivo

19. Organic anion transporters, OAT1 and OAT3, are crucial biopterin transporters involved in bodily distribution of tetrahydrobiopterin and exclusion of its excess

20. Effects of asarinin on dopamine biosynthesis and 6-hydroxydopamine-induced cytotoxicity in PC12 cells

21. Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3β/β-Catenin Signaling Pathway

22. Chronic Silymarin, Quercetin and Naringenin Treatments Increase Monoamines Synthesis and Hippocampal Sirt1 Levels Improving Cognition in Aged Rats

23. Neuroprotective Effects and Mechanisms of Action of Multifunctional Agents Targeting Free Radicals, Monoamine Oxidase B and Cholinesterase in Parkinson’s Disease Model

24. Prenatal nicotine exposure decreases the release of dopamine in the medial frontal cortex and induces atomoxetine-responsive neurobehavioral deficits in mice

25. Manganese-Mediated Decrease in Levels of c-RET and Tyrosine Hydroxylase Expression In Vitro

26. Functional state of the nigrostriatal system of Krushinsky–Molodkina rats during audiogenic seizure expression

27. Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson’s disease treated with L-DOPA

28. N-Propargyl Caffeamide (PACA) Ameliorates Dopaminergic Neuronal Loss and Motor Dysfunctions in MPTP Mouse Model of Parkinson’s Disease and in MPP+-Induced Neurons via Promoting the Conversion of proNGF to NGF

29. Neuroanatomical circuitry between kidney and rostral elements of brain: a virally mediated transsynaptic tracing study in mice

30. Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson’s disease

31. Pure autonomic failure without synucleinopathy

32. Cyclooxygenase-2 Directs Microglial Activation-Mediated Inflammation and Oxidative Stress Leading to Intrinsic Apoptosis in Zn-Induced Parkinsonism


Questions?

Drop us a message.